Issue Date | Title | Author(s) |
2019-05-22 | Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations | Liu, L; Zhang, X; Liu, Y; Zhang, L; Zheng, J; Wang, J; Hansbro, PM; Wang, L; Wang, G; Hsu, ACY |
2019-12-01 | COPD treatment choices based on blood eosinophils: Are we there yet? | Oliver, B; Tonga, K; Darley, D; Rutting, S; Zhang, X; Chen, H; Wang, G |
2020-02-05 | Why Do Intrauterine Exposure to Air Pollution and Cigarette Smoke Increase the Risk of Asthma? | Wang, B; Chen, H; Chan, YL; Wang, G; Oliver, BG |
2022-07 | Sputum Metabolomic Profiling Reveals Metabolic Pathways and Signatures Associated With Inflammatory Phenotypes in Patients With Asthma. | Liu, Y; Zhang, X; Zhang, L; Oliver, BG; Wang, HG; Liu, ZP; Chen, ZH; Wood, L; Hsu, AC-Y; Xie, M; McDonald, V; Wan, HJ; Luo, FM; Liu, D; Li, WM; Wang, G |
2022-12-06 | Reduced Skeletal Muscle Mass Is Associated with an Increased Risk of Asthma Control and Exacerbation. | Zhang, S; Zhang, X; Deng, K; Wang, C; Wood, LG; Wan, H; Liu, L; Wang, J; Zhang, L; Liu, Y; Cheng, G; Gibson, PG; Oliver, BG; Luo, F; McDonald, VM; Li, W; Wang, G |
2022-09 | Development and validation of a noninvasive prediction model for identifying eosinophilic asthma. | Li, M; Wen Ma, Z; Jun Deng, S; Oliver, BG; Wang, T; Ping Zhang, H; Wang, L; McDonald, VM; Wang, J; Liu, D; Gibson, PG; Ming Luo, F; Min Li, W; Jing Wan, H; Wang, G |
2022-10 | Endogenous Adenosine 5'-Monophosphate, But Not Acetylcholine or Histamine, is Associated with Asthma Control, Quality of Life, and Exacerbations. | Fang, XM; Liu, Y; Wang, J; Zhang, X; Wang, L; Zhang, L; Zhang, HP; Liu, L; Huang, D; Liu, D; Deng, K; Luo, FM; Wan, HJ; Li, WM; Wang, G; Oliver, BG |
2021 | Small Airway Dysfunction in Asthma Is Associated with Perceived Respiratory Symptoms, Non-Type 2 Airway Inflammation, and Poor Responses to Therapy. | Liu, Y; Zhang, L; Li, HL; Liang, BM; Wang, J; Zhang, X; Chen, ZH; Zhang, HP; Xie, M; Wang, L; Wang, G; Oliver, BG |
2020-10-01 | SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro | Hsu, AC-Y; Wang, G; Reid, AT; Veerati, PC; Pathinayake, PS; Daly, K; Mayall, JR; Hansbro, PM; Horvat, JC; Wang, F; Wark, PA |
2021-06 | Heterogeneity of Paucigranulocytic Asthma: A Prospective Cohort Study with Hierarchical Cluster Analysis. | Deng, K; Zhang, X; Liu, Y; Zhang, L; Wang, G; Feng, M; Oliver, BG; Wang, L; Hansbro, PM; Qin, L; Xie, M; Chen, ZH; Simpson, J; Zhang, J; Li, WM; Wang, G; Gibson, PG |